Search

3 win chemistry Nobel; findings led to best-selling drug

3 WIN CHEMISTRY NOBEL; FINDINGS LED TO BEST-SELLING DRUG

STOCKHOLM - Three researchers who "harnessed the power of evolution" to produce enzymes and antibodies that have led to a new best-selling...

A NEW WAY TO MANUFACTURE SMALL BATCHES OF BIOPHARMACEUTICALS ON DEMAND

Biopharmaceuticals, a class of drugs comprising proteins such as antibodies and hormones, represent a fast-growing sector of the pharmaceutical...

 
 
 

DATABASE ASSISTANT - PLANNING GROUP - BIOLEGEND - SAN DIEGO, CA

Previous experience in life science, biotechnology industry or process manufacturing industry. BioLegend develops world-class, cutting-edge...

BIOCEPT AWARDED PATENT IN HONG KONG FOR ITS TARGET SELECTOR PLATFORM USING ANTIBODIES AND A MICROCHANNEL TO PERFORM LIQUID BIOPSY

Expands the Company's global patent estate for the capture and detection of rare cells of interest, including CTCs shed by solid tumors,...

 
 
 
DNA Vaccine: New Hope for HPV-related Head and Neck Cancer

DNA VACCINE: NEW HOPE FOR HPV-RELATED HEAD AND NECK CANCER

A therapeutic vaccine MEDI0457 can boost antibodies and T cells, helping them infiltrate tumors and fight off human papillomavirus...

RACING UCB AND ROIVANT, ARGENX CLEARS PHASE 2 IN PRIMARY IMMUNE THROMBOCYTOPENIA

Argenx has posted phase 2 data on efgartigimod in primary immune thrombocytopenia. The results hint at the efficacy of the antibody...

 
 
 

A CONCEPTUAL MODEL FOR OPTIMIZING VACCINE COVERAGE TO REDUCE VECTOR-BORNE INFECTIONS IN THE PRESENCE OF ANTIBODY-DEPENDENT ENHANCEMENT

Many vector-borne diseases co-circulate, as the viruses from the same family are also transmitted by the same vector species. For example,...

IZANA STARTS PROOF-OF-CONCEPT TRIAL FOR SPINAL ARTHRITIS DRUG

U.K. startup Izana has started recruiting patients into its phase 2a trial of its anti-GM-CSF antibody namilumab in ankylosing spondylitis,...

 
 
 
Best Way to Stop Ebola Virus - Pack a Punch of Powerful Antibodies

BEST WAY TO STOP EBOLA VIRUS - PACK A PUNCH OF POWERFUL ANTIBODIES

Ebola virus experts have found that the best way to stop Ebola virus is to pack a 'one-two punch of powerful antibodies'

CRITICAL ASSESSMENT OF THE EFFICIENCY OF CD34 AND CD133 ANTIBODIES FOR ENRICHMENT OF RABBIT HEMATOPOIETIC STEM CELLS

Biotechnology Progress, EarlyView.

 
 
 

JC1801: LAB TECHNICIAN

ProSci Inc is a biotechnology company focused on developing polyclonal and monoclonal antibodies and is an expert in providing custom...

ANTIBODY EXPRESSION STABILITY IN CHO CLONALLY DERIVED CELL LINES AND THEIR SUBCLONES: ROLE OF METHYLATION IN PHENOTYPIC AND EPIGENETIC HETEROGENEITY

Biotechnology Progress, EarlyView.

 
 
 

AFTER ITS RECENT FUNDING ROUND, HIFIBIO PENS TAKEDA R&D COLLABORATION

HiFiBiO Therapeutics has signed a deal with Japanese Big Pharma and biotech friend Takeda to work on antibody therapies for various...

 
 
 

THERMO FISHER SCIENTIFIC TO PROVIDE ANTIBODY PUBLICATION DATA ON ITS WEBSITE

Researchers can view published data on antibodies directly on the website to help better understand antibody performance CARLSBAD,...

Top Veterinary Articles of the Week: Monoclonal Antibody Therapy, Dilated Cardiomyopathy, and more

TOP VETERINARY ARTICLES OF THE WEEK: MONOCLONAL ANTIBODY THERAPY, DILATED CARDIOMYOPATHY, AND MORE

Canine Lymphoma Update Dr. Sue Ettinger "You may have heard it's coming, and now it's here: monoclonal antibody therapy to assist in...

 
 
 
Experimental HIV vaccine may prevent DOZENS of strains of the virus

EXPERIMENTAL HIV VACCINE MAY PREVENT DOZENS OF STRAINS OF THE VIRUS

Researchers have created a new experimental vaccine that could neutralize dozens of strains of HIV by creating proteins that send antibodies...

PARAPRED: ANTIBODY PARATOPE PREDICTION USING CONVOLUTIONAL AND RECURRENT NEURAL NETWORKS

AbstractMotivationAntibodies play essential roles in the immune system of vertebrates and are powerful tools in research and diagnostics....

 
 
 

SOLID‐PHASE ENZYMATIC REMODELING PRODUCES HIGH YIELDS OF SINGLE GLYCOFORM ANTIBODIES

Biotechnology Journal, Volume 13, Issue 4 , April 2018.

Combination Cancer Immunotherapy to Improve Response Rates

COMBINATION CANCER IMMUNOTHERAPY TO IMPROVE RESPONSE RATES

The combination of PD-1/L1 antibodies with anti-CD27 will lead to a better response rate in cancer patients.